omeprazole / sodium bicarbonate Pill
- RxCUI
- 1161025
- RxNorm name
- omeprazole / sodium bicarbonate Pill
- Term type
- SCDG
- Status
- Active
- Updated
- 2026-10-03 19:22:56
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 102011
- Active start
- 102011
- Multiple ingredient
- YES
- Branded
- NO
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| sodium bicarbonate | 36676 |
| omeprazole | 7646 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | omeprazole / sodium bicarbonate Pill | 1 | NAMES |
| RxNorm Name | omeprazole / sodium bicarbonate Pill | 1 | NAMES |
| TTY | SCDG | 1 | ATTRIBUTES |
| RxCUI | 1161025 | 1 | CODES |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
No records found.
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | B05XA | Electrolyte solutions | ATC1-4 | sodium bicarbonate | |
| ATC | A02BC | Proton pump inhibitors | ATC1-4 | omeprazole | |
| ATC | B05CB | Salt solutions | ATC1-4 | sodium bicarbonate | |
| FDASPL | N0000175525 | Proton Pump Inhibitor | EPC | has_epc | omeprazole |
| FDASPL | N0000182140 | Cytochrome P450 2C19 Inhibitors | MOA | has_moa | omeprazole |
| FDASPL | N0000000147 | Proton Pump Inhibitors | MOA | has_moa | omeprazole |
| MEDRT | D009853 | Omeprazole | CHEM | has_ingredient | omeprazole |
| MEDRT | D017693 | Sodium Bicarbonate | CHEM | has_ingredient | sodium bicarbonate |
| MEDRT | D000141 | Acidosis, Renal Tubular | DISEASE | may_treat | sodium bicarbonate |
| MEDRT | D000471 | Alkalosis | DISEASE | ci_with | sodium bicarbonate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | sodium bicarbonate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | omeprazole |
| MEDRT | D062787 | Drug Overdose | DISEASE | may_treat | sodium bicarbonate |
| MEDRT | D064420 | Drug-Related Side Effects and Adverse Reactions | DISEASE | may_prevent | sodium bicarbonate |
| MEDRT | D004381 | Duodenal Ulcer | DISEASE | may_treat | omeprazole |
| MEDRT | D004415 | Dyspepsia | DISEASE | may_treat | sodium bicarbonate |
| MEDRT | D004487 | Edema | DISEASE | ci_with | sodium bicarbonate |
| MEDRT | D004941 | Esophagitis | DISEASE | may_treat | omeprazole |
| MEDRT | D005764 | Gastroesophageal Reflux | DISEASE | may_treat | sodium bicarbonate |
| MEDRT | D005764 | Gastroesophageal Reflux | DISEASE | may_treat | omeprazole |
| MEDRT | D006323 | Heart Arrest | DISEASE | may_treat | sodium bicarbonate |
| MEDRT | D006356 | Heartburn | DISEASE | may_treat | omeprazole |
| MEDRT | D006356 | Heartburn | DISEASE | may_treat | sodium bicarbonate |
| MEDRT | D016481 | Helicobacter Infections | DISEASE | may_treat | omeprazole |
| MEDRT | D006947 | Hyperkalemia | DISEASE | may_treat | sodium bicarbonate |
| MEDRT | D006955 | Hypernatremia | DISEASE | ci_with | sodium bicarbonate |
| MEDRT | D006996 | Hypocalcemia | DISEASE | ci_with | sodium bicarbonate |
| MEDRT | D011654 | Pulmonary Edema | DISEASE | ci_with | sodium bicarbonate |
| MEDRT | D013276 | Stomach Ulcer | DISEASE | may_treat | omeprazole |
| MEDRT | D015043 | Zollinger-Ellison Syndrome | DISEASE | may_treat | omeprazole |
| MEDRT | N0000000226 | Acid-Base Activity | MOA | has_moa | sodium bicarbonate |
| MEDRT | N0000000220 | Electrolyte Activity | MOA | has_moa | sodium bicarbonate |
| MEDRT | N0000000147 | Proton Pump Inhibitors | MOA | has_moa | omeprazole |
| MEDRT | N0000009054 | Gastric Acid Alteration | PE | has_pe | sodium bicarbonate |
| MEDRT | N0000009549 | Increased Renal HCO3- Excretion | PE | has_pe | sodium bicarbonate |
| MEDRT | N0000009724 | Inhibition Gastric Acid Secretion | PE | has_pe | omeprazole |
| MEDRT | N0000000026 | Hepatic Metabolism | PK | site_of_metabolism | omeprazole |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 20 MG / 1100 MG |
| ATTRIBUTES | AVAILABLE_STRENGTH | 40 MG / 1100 MG |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |